CEO Dave Ricks said Monday that the company's GLP-1 weight-loss pill orforglipron could receive FDA approval as soon as early ...
As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama sheds light on the pharmaceuticals industry behind them ...
Bloomberg on MSN56m
Eli Lilly CEO on Fighting Cancer and Obesity, Drug PricingEli Lilly & Co. Chief Executive Officer Dave Ricks talks about paying $2.5 billion for a cancer drug being developed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback